Overview

Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine blood concentration evolution of capecitabine and its active metabolites, in elderly patient 75 years and more.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Limoges
Treatments:
Capecitabine